U.S. market Closed. Opens in 1 day 6 minutes

NEPH | Nephros, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.5300 - 1.5707
52 Week Range 1.3600 - 4.04
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 8,722
Average Volume 11,458
Shares Outstanding 10,544,200
Market Cap 16,238,068
Sector Healthcare
Industry Medical - Instruments & Supplies
IPO Date 2004-09-21
Valuation
Profitability
Growth
Health
P/E Ratio -17.11
Forward P/E Ratio N/A
EPS -0.09
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 31
Country USA
Website NEPH
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
NEPH's peers: ZTEK, AVGR, EKSO, FEMY, POCI, KRMD, INFU, UTMD, MLSS, PDEX, CLPBY, OPSSF, SAUHY, TPGVF
*Chart delayed
Analyzing fundamentals for NEPH we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see NEPH Fundamentals page.

Watching at NEPH technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on NEPH Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙